The QualityStocks Daily Friday, Novemeber 8th, 2024

Today's Top 3 Investment Newsletters

QualityStocks(NVOS) $0.0558 +86.00%

Premium Stock Alerts(TIVC) $0.4059 +55.82%

MarketClub Analysis(NCL) $0.3340 +48.84%

The QualityStocks Daily Stock List

Novo Integrated Sciences (NVOS)

QualityStocks, MarketClub Analysis, StockEarnings, TradersPro, Premium Stock Alerts, The Stock Dork, StocksEarning and InvestorsUnderground reported earlier on Novo Integrated Sciences (NVOS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) offers healthcare services. The Company provides products and services for the healthcare industries through the integration of healthcare, technology, and medical services. It serves customers in the United States and Canada.

The firm offers specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, chiropodist, neurological functions, kinesiology and dental services. Its multi-disciplinary healthcare services and protocols are directed at assessment, treatment, management, rehabilitation, and prevention through its clinics, affiliate clinics, retirement homes, and long-term care facilities. The company was founded by Michael H. Rouse on November 27, 2000 and is headquartered in Bellevue, WA. It is a subsidiary of ALMC-ASAP Holdings, Inc.

Novo Integrated Sciences is a Nevada "C" corporation (originally incorporated in Delaware on November 27, 2000 and subsequently converted on February 20, 2008).

It offers multidisciplinary primary healthcare-related services and products. The company operates through its subsidiary Novo Healthnet Limited (Nova). Novo provides its services and products through both clinic and eldercare related operations. Nova’s services include manual/manipulative therapy, occupational therapy, functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, women’s pelvic health programs, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education and private personal training. It also provides nutraceutical health solutions. The company’s subsidiaries also include Novo Assessments, Inc., Novo Healthnet Rehab Limited, Novomerica and an 80% interest in Novo Healthnet Kemptville Center, Inc.

In addition, the company offers specialty treatment and recovery programs derived from motor vehicle accident injuries, long-term disability cases, corporate wellness, and job-site injuries. Further, it provides cold laser therapeutics, shockwave therapy, custom bracing and orthotics, custom compression therapy/stockings, and lymphatic drainage treatment. The company offers medical technology services, such as telemedicine and remote patient monitoring. It operates 16 owned clinics, a contracted network of 102 affiliate clinics, and 220 eldercare related care homes, as well as retirement homes and community-based locations in Canada.

Novo Integrated Sciences (NVOS), closed Friday's trading session at $0.0558, up 86%, on 1,965,782 volume. The average volume for the last 3 months is 2.784M and the stock's 52-week low/high is $0.027/$2.1208.

Applied Optoelectronics (AAOI)

StockEarnings, StocksEarning, Zacks, MarketBeat, MarketClub Analysis, Schaeffer's, InvestorPlace, StreetInsider, The Street, TradersPro, QualityStocks, Barchart, StockMarketWatch, Kiplinger Today, INO Market Report, The Online Investor, Daily Trade Alert, The Best Newsletters, Profit Confidential, InvestingChatter, Investment House, Investment News Daily, BUYINS.NET, Trades Of The Day, InsiderTrades, InvestmentHouse, Hit and Run Candle Sticks, Investment U, Rick Saddler, TraderPower, Louis Navellier, The Stock Dork, MarketMovingTrends, Investopedia, The Daily Market Alert, Early Bird, FreeRealTime, Market Intelligence Center Alert, INO.com Market Report, Investing Futures, Investing Signal, Marketbeat.com, InvestorsUnderground and Short Term Wealth reported earlier on Applied Optoelectronics (AAOI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Applied Optoelectronics Inc. (NASDAQ: AAOI) (FRA: A59) is focused on designing, manufacturing and selling different fiber-optic networking products.

The firm has its headquarters in Sugar Land, Texas and was incorporated in 1997, on February 28th by Chih Hsiang Lin. It serves consumers across the globe, with a focus on the United States, the People’s Republic of China and Taiwan.

The company operates in Taipei, Ningbo and Taiwan and China, via its wholly owned subsidiary known as Prime World International Holdings Limited. This subsidiary operates a branch in Taipei, Taiwan, which is mainly involved in the manufacture of transceivers. It also conducts research and development activities for its transceiver products. In addition to this, the company has a research and development facility in the state of Georgia. Its customers include Microsoft, Facebook, Amazon, Cisco Systems and Arris Group. The company generates the majority of its revenue from Taiwan and China.

The enterprise uses its Molecular Beam Epitaxy fabrication process to manufacture its products, which include transceivers, transmitters, turn-key equipment and optical devices like photodiodes, subassemblies and laser diodes, as well as distribution, node and headend equipment, which allow for faster connections. It sells its products through indirect and direct sales channels. The enterprise serves the telecom equipment manufacturer, fiber-to-the-home, Cable Television Broadband and internet data center markets.

The firm recently released its financial results for the third quarter of 2021, with its CEO noting that they had observed an improvement in Datacom. Currently, the firm is focused on growing its CATV business.

Applied Optoelectronics (AAOI), closed Friday's trading session at $27.76, up 55.0838%, on 19,430,463 volume. The average volume for the last 3 months is 160,884 and the stock's 52-week low/high is $6.70/$27.805.

Rigel Pharmaceuticals (RIGL)

MarketClub Analysis, Greenbackers, StockMarketWatch, MarketBeat, BUYINS.NET, StreetInsider, Schaeffer's, The Street, InvestorPlace, Wall Street Resources, TraderPower, Zacks, Kiplinger Today, INO.com Market Report, SmarTrend Newsletters, Stock Stars, MonsterStocksPicks, StockOodles, FreeRealTime, Candle Stick Forum, Cabot Wealth, Barchart, Marketbeat.com, WealthMakers, David Peltier, GreatStockPix, 360wallstreet, 24-7 Stock Alert, Investing Daily, iStockAnalyst, Jason Bond, 24/7 Trader, PennyOmega, Promotion Stock Secrets, QualityStocks, Stock Beast, Streetwise Reports, The Stock Dork, TopStockAnalysts, TradersPro, Wealth Daily, Wealth Insider Alert and MegaPennyStocks reported earlier on Rigel Pharmaceuticals (RIGL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) (FRA: RI2A) is a clinical stage biotechnology firm that is engaged in the discovery and development of new treatments for autoimmune and inflammatory ailments and also hematologic and muscle disorders.

The company has its headquarters in South San Francisco, California and was incorporated in 1996, on June 14 by Ronald B. Garren, Garry P. Nolan, Thomas A. Raffin, James M. Gower and Donald G. Payan.

The firm has license and research agreements with Daiichi Sankyo for the development of murine double minute 2 inhibitors for hematological and solid malignancies; BerGenBio AS for developing and commercializing AXL inhibitors in oncology; AstraZenecaAB for commercializing and developing an inhaled janus kinase inhibitor known as R256 and another with Aclaris Therapeutics International Limited for commercializing and developing JAK inhibitors for treating alopecia areata and other dermatological conditions. It is also party to a supply and license agreement with Kissei Pharmaceutical Co. Ltd for the development and commercialization of Fostamatinib.

The firm’s product candidates include Fostamatinib, which is currently in phase 3 clinical trial for the treatment of the coronavirus; a phase 2 clinical trial to test its effectiveness in treating hospitalized coronavirus patients and phase 3 clinical trial testing its effectiveness in treating warm autoimmune hemolytic anemia. This is in addition to developing an oral tyrosine kinase inhibitor indicated for treating adult patients suffering from chronic immune thrombocytopenia called Tavalisse; an oral interleukin receptor inhibitor called R835 which is undergoing a phase 1 clinical trial for hematology-oncology, inflammatory and autoimmune ailments and a receptor-interacting kinase 1 inhibitor which recently concluded phase 1 clinical trials for inflammatory and autoimmune ailments called R552.

Rigel Pharmaceuticals (RIGL), closed Friday's trading session at $22.07, up 42.9404%, on 1,324,526 volume. The average volume for the last 3 months is 363,734 and the stock's 52-week low/high is $7.4843/$22.85.

Athena Bitcoin Global (ABIT)

We reported earlier on Athena Bitcoin Global (ABIT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Athena Bitcoin Global (OTC: ABIT) is a digital asset tech firm that operates a network of cryptocurrency ATMs in North America and South America.

The firm has its headquarters in Chicago, Illinois and was incorporated in 1981, on August 26th by Sam Sesay. Prior to its name change, the firm was known as GamePlan Inc. It operates as part of the securities and commodity contracts intermediation and brokerage industry. The firm has two companies in its corporate family and serves consumers around the globe.

The company mines cryptocurrencies, with a focus on the generation of digital assets and the blockchain ecosystem. Its objective is to build open financial systems that serve the global community. The company’s solutions allow the opportunity and freedom to invest, spend, build and save.

The enterprise has developed a financial platform known as Athena RURU, which facilitates the use of digital currencies and electronic banking to power economies. Its peer-to-peer exchanges, i.e. MercadoAthena.com and BitQuick.com, allow individuals to sell and buy bitcoin and bitcoin cash without using an ATM. The enterprise also offers advisory services on a range of fixed income and equity transactions for real estate developers and firms. Its Bitcoin locations include El Salvador, Colombia, Argentina, Texas, Puerto Rico, Pennsylvania, Ohio, Missouri, Michigan, Illinois, Georgia, Florida, California and Alabama. The enterprise also operates a foundation for middle school and high school students.

The firm is focused on building alliances for a better financial world, which will not only bring in more opportunities for investment and growth but also benefit its shareholders.

Athena Bitcoin Global (ABIT), closed Friday's trading session at $0.199, up 42.2445%, on 2,738,663 volume. The average volume for the last 3 months is 835,414 and the stock's 52-week low/high is $0.02075/$0.44.

Anavex Life Sciences Corp. (AVXL)

StocksEarning, MarketBeat, StockEarnings, SmarTrend Newsletters, QualityStocks, MarketClub Analysis, PennyStocks24, BUYINS.NET, StockMarketWatch, StreetInsider, Schaeffer's, StockOodles, The Street, Zacks, Top Pros' Top Picks, InvestorPlace, Marketbeat.com, TraderPower, BestStocksDaily, Investors Alley, HoleinOneStocks.net, PennyPro, Trading Desk, SmallCap Network, TradersPro, Primoris Group, OTC Markets Group, Top Stock Picks, Pennybuster, Investment House, UltimatePennyStock, Oakshire Financial, SmallCapGrowth, Market FN, KingPennyStocks, PinnacleDigest, StreetAuthority Financial, AnotherWinningTrade, The Wall Street Transcript, The Best Newsletters, Insider Wealth Alert, Wyatt Investment Research, smartOTC, StockRunway, Dividend Opportunities, Stock Research Newsletter, Trade of the Week, CustomerService, MadMoneyPennyStocks, M2 Communications, AwesomeStocks, Daily Market Beat, Buzz Stocks, Barchart, Jason Bond, Investing Futures, CrazyStocks, Chatter Box Stocks, Investor Ideas, JediPennyStocks, SmallCapVoice, Tiny Gems, TheStockAdvisors, The Stock Dork, TerrificPennyStocks, TopPennyStockMovers, Total Wealth, StockBlogs, Stock News Now, Stock Beast, SquawkBoxStocks, VectorVest, SmallMovesBigGains, Market Intelligence Center, Shah's Insights & Indictments, AimHighProfits, Premium Stock Alerts, Power Profit Trades, PhD-Trading, Promotion Stock Secrets, Oakshire News Bulletin, Money Morning, Wall Street Elite, Wealth Daily and SpecialPennyStocks reported earlier on Anavex Life Sciences Corp. (AVXL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company listed on the NasdaqCM. It is developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, pain, and different kinds of cancer. These includes Alzheimer’s disease, Parkinson’s disease, Rett syndrome, and other central nervous system (CNS) diseases. The Company is pursuing large markets with high unmet need through applying genetic precision medicine. Anavex Life Sciences has its corporate headquarters in New York, New York.

The Company’s lead drug candidate is ANAVEX®2-73 (blarcamesine). It recently completed a successful Phase 2a clinical trial for Alzheimer’s disease. ANAVEX®2-73 (blarcamesine) is an orally available drug candidate. It restores cellular homeostasis through targeting sigma-1 and muscarinic receptors. Preclinical studies demonstrated its potential to halt and/or reverse the course of Alzheimer’s disease.

Additionally, ANAVEX®2-73 (blarcamesine) exhibited anticonvulsant, anti-amnesic, neuroprotective, as well as anti-depressant properties in animal models. This indicates its potential to treat additional CNS disorders, including epilepsy. The Michael J. Fox Foundation for Parkinson’s Research earlier awarded Anavex Life Sciences a research grant that fully funded a preclinical study to develop ANAVEX®2-73 (blarcamesine) for the treatment of Parkinson’s disease.

ANAVEX®3-71, which targets sigma-1 and muscarinic receptors, is a promising preclinical drug candidate demonstrating disease-modifying activity against the major hallmarks of Alzheimer’s disease in transgenic (3xTg-AD) mice. This includes cognitive deficits, amyloid, and tau pathologies. In preclinical trials, ANAVEX®3-71 has shown beneficial effects on mitochondrial dysfunction and neuroinflammation.

In August, Anavex Life Sciences announced that patients from the ANAVEX®2-73-003 Phase 2a Alzheimer’s disease trial will continue treatment with ANAVEX®2-73 (blarcamesine) through the Australian Government Department of Health - Therapeutic Goods Administration (TGA) compassionate use Special Access Scheme following completion of over 5-years daily dosing of ANAVEX®2-73 (blarcamesine) and recommendation by their physicians. The TGA approved the Special Access Scheme Category B applications based on the safety profile of ANAVEX®2-73 (blarcamesine), and also clinical evidence that ANAVEX®2-73 (blarcamesine) may benefit patients.

Anavex Life Sciences Corp. (AVXL), closed Friday's trading session at $9.24, up 21.0216%, on 2,945,807 volume. The average volume for the last 3 months is 665,242 and the stock's 52-week low/high is $3.25/$10.45.

iTeos Therapeutics (ITOS)

MarketBeat, StreetInsider, The Street, Schaeffer's and InvestorPlace reported earlier on iTeos Therapeutics (ITOS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

iTeos Therapeutics Inc. (NASDAQ: ITOS) is a clinical-stage biopharmaceutical firm focused on discovering and developing immune-oncology therapeutics for patients with cancer.

The firm has its headquarters in Watertown, Massachusetts and was incorporated in April 2012 by Michel Detheux. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers around the globe, with a focus on those in Belgium and the United States.

iTeos Therapeutics designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer.

The enterprise’s pipeline includes three clinical-stage programs targeting novel, validated immuno-oncology pathways. Its lead antibody product candidate, belrestotug (EOS-448/GSK4428859A), is an antagonist of TIGIT, an immune checkpoint with multiple mechanisms of action. Its advanced program is inupadenant, also known as EOS-850, a next-generation adenosine 2A receptor (A2AR) antagonist tailored to overcome the specific adenosine-mediated immunosuppression found in the tumor microenvironment. Its program to initiate clinical trials is EOS-984, a potentially first-in-class small molecule focused on a new mechanism in the adenosine pathway by targeting equilibrative nucleoside transporter 1 (ENT1), a dominant transporter of adenosine on lymphocytes involved in T cell metabolism.

The firm, which announced recently that preclinical, translational, and clinical data from inupadenant would be presented at the upcoming European Society for Medical Oncology Immuno-Oncology Congress 2024, has asserted that its conviction in the potential of the belrestotug and dostarlimab doublet only continues to grow. It remains committed to growing its pipeline and fielding for new opportunities to advance its research and bolster its overall growth.

iTeos Therapeutics (ITOS), closed Friday's trading session at $9.27, up 0.9803922%, on 372,778 volume. The average volume for the last 3 months is 7.256M and the stock's 52-week low/high is $8.41/$18.75.

QuantumScape Corp. (QS)

StockEarnings, Schaeffer's, InvestorPlace, QualityStocks, StocksEarning, MarketClub Analysis, The Street, MarketBeat, GreenCarStocks, The Online Investor, Cabot Wealth, FreeRealTime, Daily Trade Alert, Top Pros' Top Picks, Earnings360, Atomic Trades, BUYINS.NET, CNBC Breaking News, Early Bird, INO Market Report, 360 Wall Street, wyatt research newsletter, Zacks, Premium Stock Alerts, Trades Of The Day, TipRanks and Green Energy Stocks reported earlier on QuantumScape Corp. (QS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Data from the Society of Motor Manufacturers and Traders (SMMT) has revealed that electric vehicle sales in the United Kingdom (UK) have risen despite an overall drop in vehicle sales. The lobby Group’s data shows that EV sales were up in October as automakers sold 29,800 cars while petrol and diesel vehicle sales dropped by 14% and 25%, respectively.

Electric vehicle sales also increased by a quarter in October compared to October 2023 amidst efforts by carmakers to meet government emission standards, SMMT data shows. On the other hand, overall vehicle sales in October fell by 6% year-over-year, with diesel-powered car sales falling by 25% and petrol vehicle sales dropping by 14% as market demand for new vehicles wanes.

The United Kingdom’s zero-emission vehicle (ZEV) mandate requires that carmakers sell an increasingly larger share of battery electric vehicles (BEVs) every year as part of the country’s efforts to lower greenhouse gas emissions in the transport sector and combat climate change. The result is a wave of new EV models from several automakers and surging electric vehicle sales as more consumers opt for zero-emission vehicles over the familiarity of gas-powered cars.

Electric vehicle sales were especially high in September, and EVs now account for 18.1% of total sales in the UK, up from 15.6% at the same time last year. However, the car industry is trying to convince the UK government to either extend the electric vehicle mandate or provide subsidies to incentivize EV purchases as automakers are currently using discounts to encourage sales.

While this technique can attract buyers in the short term, it isn’t sustainable in the long term. Government incentives and subsidies have been critical to spurring sales in the nascent electric vehicle industry for the majority of its existence due to the prohibitively high costs involved in EV development. With the UK government eliminating EV subsidies for individual drivers in 2022, automakers seemingly have no choice but to offer discounted prices, even at the cost of their bottom lines, to meet the UK’s EV mandate.

Auto Trader reports that new electric vehicle discounts on the car trading site hit a high of 12.4% in October compared to 9% for internal combustion engine cars. Even so, climate-focused campaigners and analysts encourage the government to maintain its electrification timeline as the ZEV mandate has been effective so far.

SMMT chief executive Mike Hawes says a mass transition to electric cars at the ZEV mandate’s required pace will require major government intervention in regulation, infrastructure, and incentives.

The rising EV sales in the UK could provide the impetus that new battery chemistry developers like QuantumScape Corp. (NYSE: QS) need to move things faster and benefit from the upsurge in electric vehicle adoption.

QuantumScape Corp. (QS), closed Friday's trading session at $5.02, up 0.6012024%, on 13,796,855 volume. The average volume for the last 3 months is 11.809M and the stock's 52-week low/high is $4.67/$10.03.

Meta Platforms Inc. (META)

Zacks, The Street, InvestorPlace, Early Bird, Schaeffer's, Investopedia, MarketBeat, MarketClub Analysis, The Online Investor, Kiplinger Today, INO Market Report, Cabot Wealth, TipRanks, QualityStocks, Top Pros' Top Picks, Louis Navellier, The Daily Market Alert, The Night Owl, Money Wealth Matters, DividendStocks, AllPennyStocks, MarketMovingTrends, InsiderTrades, Trading Tips, TradersPro, FreeRealTime, Daily Wealth, Eagle Financial Publications, Investment House, TradeSmith Daily, TradingPub, Inside Trading, Trading with Larry Benedict, The Wealth Report, InvestorIntel, Market Trends, Rick Saddler, CNBC Breaking News, Smartmoneytrading, Jea Yu, Investing Breakout, Investing Daily, StockReport, Stansberry Research, Marketbeat.com, Top Pros Top Picks, Investors Underground, Jon Markman’s Pivotal Point, Smart Investing Society, Trade Out Loud, The Stock Dork, bullseyeoptiontrading, Contrarian Outlook, Earnings360, Empire Financial Daily, empirefinancialresearch, Don Kaufman, Wealth Daily, Chaikin Analytics, Financial Newsletter, wyatt research newsletter, 360 Wall Street, Timothy Sykes, The Investing Insider, The SmartMoneyTrading, Prism MarketView, Premium Stock Alerts, OTC Stock Review, On Options, TheoTrade, Investor News, Tim Bohen, Hit and Run Candle Sticks, 1 2 3 Trade Option, Jeff Bishop, Investor's Business Daily, The Motley Fool, TradeSmith, Trading Pub, iDigital Market and Mind Over Markets reported earlier on Meta Platforms Inc. (META), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Meta (NASDAQ: META) is a leading technology company known for its social media platforms, including Facebook, Instagram and WhatsApp. The company plays a significant role in the digital landscape, providing services that connect billions of users worldwide. Meta faces competition from other tech giants like Google, X and TikTok, which also offer platforms for user-generated content.

The recent dismissal of a lawsuit against Meta concerning Section 230 is a notable legal victory for the company. Section 230 is a crucial law that protects tech companies from being held liable for user-generated content on their platforms. This legal shield allows Meta to operate its platforms without the constant threat of litigation over the content users post.

The lawsuit involved a professor who aimed to release software that would enable users to automatically unfollow everyone in their Facebook feed. The dismissal of this case reinforces the protections that Section 230 provides to Meta and similar companies, ensuring they can continue to host user content without facing legal repercussions for third-party actions.

Meta’s shares reached a high of $593.10 today. This stock movement reflects investor confidence in the company’s ability to navigate legal challenges and maintain its position in the tech industry. The dismissal of the lawsuit likely contributes to this positive sentiment, as it secures Meta’s legal standing under Section 230.

To view the company’s most recent earnings release, visit https://ibn.fm/UDAiT

About Meta Platforms Inc.

Meta builds technologies that help people connect, find communities and grow businesses. When Facebook launched in 2004, it changed the way people connect. Apps like Messenger, Instagram and WhatsApp further empowered billions around the world. Now, Meta is moving beyond 2D screens toward immersive experiences like augmented and virtual reality to help build the next evolution in social technology. For more information, visit the company’s website at https://investor.FB.com.

Meta Platforms Inc. (META), closed Friday's trading session at $589.34, off by 0.3988508%, on 9,415,699 volume. The average volume for the last 3 months is 175,567 and the stock's 52-week low/high is $313.66/$602.95.

Innovative Industrial Properties Inc. (IIPR)

InvestorPlace, QualityStocks, Kiplinger Today, The Online Investor, Top Pros' Top Picks, Schaeffer's, Daily Trade Alert, The Street, MarketBeat, DividendStocks, Wealth Insider Alert, Trades Of The Day, The Wealth Report, Zacks, CannabisNewsWire, TradersPro, FreeRealTime, StreetInsider, Stock Up Featured, StockMarketWatch, The Street Report, Investopedia, Trading Concepts, Early Bird, CFN Media Group, Stock Gumshoe, Outsider Club, Marketbeat.com, StreetAuthority Daily, TipRanks, Inside Trading, VectorVest and Wealth Daily reported earlier on Innovative Industrial Properties Inc. (IIPR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The financial race surrounding the recreational marijuana legalization initiative in South Dakota was highly competitive, with both opponents and supporters gathering nearly equal resources. This set the scene for an intense debate while voters prepared for the November 5 ballot. Both sides have collectively raised around $915,000, showcasing the deeply split opinions across the state on the matter.

Advocates for Initiated Measure 29, which aims to legalize the use and sale of cannabis for those aged 21 and over, have secured about $458,000 in funding. The main group pushing for the measure, known as the Yes on 29 Ballot Committee, has raised $436,000, with $300,000 contributed by cannabis-related businesses. The largest single donation was $100,000 from GL Partners, a Rapid City-based medical cannabis dispensary.

On the opposing front, the Protecting SD Kids Ballot Question Committee accumulated about $457,000. A large share of this funding came from individual contributions, including a notable $61,400 donation by Brad Wheeler, a local manufacturer. Additionally, businesses within South Dakota collectively contributed $71,000 to the opposition’s campaign.

The significant financial backing on both sides highlights the importance of Initiated Measure 29, one of seven ballot measures voters will decide on this November. So far, the Yes on 29 campaign has spent approximately $217,000 on its advocacy efforts, while the opposition has spent a more substantial $371,000 on initiatives to prevent the measure’s approval.

The financial records show an ongoing trend where the marijuana industry heavily invests in efforts to support legalization measures across the country. Meanwhile, those against such measures often rely on local businesses and grassroots donations to bolster their campaigns.

As election day neared, the close fundraising figures signal a tight race. Both sides stepped up their campaigns to influence voters, aware of the potential long-term effects on South Dakota’s cannabis policy.

Neighboring states also contribute to the broader conversation about cannabis reform. Montana, for instance, has already seen more than $118 million in tax revenue from its legalized marijuana market over two years. North Dakota, looking at similar economic incentives, is proposing Measure 5, which promises job creation and financial gains. In contrast, Nebraska stands apart, lacking any legalization measures and emphasizing the varied regional perspectives on cannabis policy.

Without any restrictions on donation amounts, South Dakota’s campaign on this issue represents a significant and contentious vote, making November 5 a pivotal day for the state’s future approach to cannabis regulation.

Businesses like Innovative Industrial Properties Inc. (NYSE: IIPR) with interests in the cannabis space in other markets will be hoping that the will of the people wins the day once vote counting is completed.

Innovative Industrial Properties Inc. (IIPR), closed Friday's trading session at $106.37, off by 3.3615%, on 652,823 volume. The average volume for the last 3 months is 20.142M and the stock's 52-week low/high is $73.04/$138.35.

Alibaba Group Holding Ltd. (BABA)

InvestorPlace, The Street, Kiplinger Today, Schaeffer's, MarketClub Analysis, Zacks, Money Morning, StreetInsider, Trades Of The Day, Daily Trade Alert, Marketbeat, Market Intelligence Center Alert, StocksEarning, Investopedia, The Online Investor, Wealth Insider Alert, StreetAuthority Daily, Early Bird, ProfitableTrading, CustomerService, Marketbeat.com, QualityStocks, Louis Navellier, TopStockAnalysts, Uncommon Wisdom, GorillaTrades, StockEarnings, Top Pros' Top Picks, TipRanks, Cabot Wealth, CNBC Breaking News, AllPennyStocks, Profit Confidential, The Wealth Report, Options Elite, Total Wealth, Investors Alley, INO.com Market Report, Money and Markets, Daily Profit, Street Insider, Barchart, The Street Report, Wyatt Investment Research, SmallCapVoice, StrategicTechInvestor, Investing Daily, Market Intelligence Center, Insider Wealth Alert, Power Profit Trades, Daily Wealth, Average Joe Options, Investing Signal, FreeRealTime, Trade of the Week, INO Market Report, Wealth Daily, MarketTamer, WStreet Market Commentary, Earnings360, The Best Newsletters, MarketWatch, Trader Prep, Wall Street Daily, Trading Concepts, BUYINS.NET, Short Term Wealth, Rick Saddler, Inside Investing Daily, TheOptionSpecialist, Investors Underground, Dynamic Wealth Report, InvestmentHouse, ChineseWire, StockReport, Visual Capitalist, 24/7 Trader, Investment U, OptionAlarm News, SureMoney, Investing Futures, Investing Lab, Energy and Capital, Wealthpire Inc., InvestorsHQ, Agora Financial, Daily Dividends, MarketArmor.com, The Weekly Options Trader, Eagle Financial Publications, wyatt research newsletter, Dividend Opportunities, Direction Alerts, Beat The Street, Energy & Resources Digest, Atomic Pennies, Financial Freedom Post, BillionDollarClub, DividendStocks, Chaikin PowerFeed, 24-7 Stock Alert, Goldman Small Cap Research, Equities.com, Terry's Tips, Liberty Through Wealth, Rockwell Trading, Shah's Insights & Indictments, SmallCapNetwork, Stock Gumshoe, Outsider Club, Summa Money, Navellier Growth, The Growth Stock Wire, The Night Owl, The Stock Dork, Wallstreet Journal, The Trading Report, TheoTrade, StockMarketWatch, InvestorsObserver Team, Hit and Run Candle Sticks, Inside Trading, InsiderTrades, Investiv, Investment House, Profits Run, InvestorGuide, Greenbackers, Jim Cramer, Kiplinger’s Weekly Update, Market Authority, Weekly Wizards, MarketDeal, wealthmintrplus and Investor Guide reported earlier on Alibaba Group Holding Ltd. (BABA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Alibaba Group has laid off dozens of employees from its metaverse division, Yuanjing, in light of a decline in the buzz about the metaverse. By restructuring the teams in the Shanghai and Hangzhou offices, the Chinese multinational technology company aims to enhance organizational efficiency. However, despite these cutbacks, the company reassures that its metaverse efforts will continue, focusing on metaverse tools and services for its customers.

Founded in 2021 during a period of intense enthusiasm for the metaverse, Yuanjing had been part of Alibaba Group Holding Ltd. (NYSE: BABA)‘s wider effort into virtual and augmented reality technologies. At its most successful point, the unit received investment running up to billions and employed a team of about 300 members. However, with the metaverse technologies market not meeting expectations, many companies, including Alibaba, are reassessing their investments in this space.

The move by Alibaba is not unique. Other major Chinese tech firms, such as Tencent and ByteDance, have also decided to scale back their metaverse projects, citing waning interest in the sector. These companies, along with Alibaba, are shifting their focus from the metaverse to more practical and widely adopted technologies like artificial intelligence (AI), which has seen rapid growth since the success of OpenAI’s ChatGPT.

Alibaba remains optimistic about the metaverse’s potential, with its cloud computing arm, Alibaba Cloud, continuing to position it as the “next generation of the internet.” The company highlights the metaverse’s ability to bridge the digital and physical worlds, integrating virtual experiences with real-world applications like e-commerce, remote services, and online education. Despite the layoffs, the company is committed to exploring the long-term possibilities of the metaverse.

The trend of rethinking metaverse investments is not limited to Chinese companies. Global giants, including Apple, have also scaled back their focus on augmented and virtual reality technologies. Devices like the Ray-Ban Stories and Meta’s mixed-reality headsets have not seen the consumer adoption many expected. As a result, companies are diverting their resources away from metaverse-related projects toward AI, now the new focal point of innovation.

While Alibaba’s layoffs reflect a shift away from the metaverse as a core area of investment, the company is not abandoning the sector entirely. Instead, it is realigning its resources to better match current market realities, with AI now taking center stage in the company’s growth strategy. This mirrors a broader trend across the tech industry, where enthusiasm for the metaverse has tempered in favor of more immediately impactful technologies like AI.

Alibaba Group Holding Ltd. (BABA), closed Friday's trading session at $94.19, off by 5.9417%, on 24,879,795 volume. The average volume for the last 3 months is 75,212 and the stock's 52-week low/high is $66.63/$117.82.

BitFuFu Inc. (FUFU)

QualityStocks and 360 Wall Street reported earlier on BitFuFu Inc. (FUFU), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The 2024 United States elections have significantly impacted the cryptocurrency landscape, elevating its importance within the global financial sector.

Crypto-related donations have soared past $238 million for the first time, surpassing contributions from traditional sectors like pharmaceuticals and oil. This unprecedented level of support is expected to push policymakers in Washington toward more crypto-friendly regulations.

Some of the most prominent contributors from the sector include major players such as Ripple, Coinbase, and Andreessen Horowitz. Collectively, these firms have contributed over $160 million to pro-crypto political action committees (PACs), backing candidates with crypto-friendly agendas such as John Deaton, who is running for Congress.

A report on these donations was published by analytics firm Breadcrumbs in collaboration with FOX Business. Breadcrumbs research analyst James Delmore commented on the findings, noting that the donations are sending a message from the crypto industry to lawmakers: the current cryptocurrency policies in the U.S. need reform.

Of the $238 million raised, the majority—$181 million—was funneled through super PACs, while the remaining $57 million came from individual industry players. Notable contributors include Chris Larsen, Ripple’s co-founder; the Winklevoss twins, founders of Gemini; and Ben Horowitz and Marc Andreessen, founding partners of Andreessen Horowitz.

Both Kamala Harris and Donald Trump received notable support from the crypto sector. According to data from the Federal Election Commission (FEC), Trump garnered more than half of these donations, totaling over $22 million from 17 key donors. In contrast, Kamala Harris received around $12 million, with 99% of her crypto-related donations coming from Ripple’s Chris Larsen.

Several other candidates are making competitive bids in the elections as well. In the Ohio Senate race, for instance, incumbent Democrat Sherrod Brown holds a slim 1% lead over Republican challenger Bernie Moreno. Moreno has actively courted crypto supporters, with pro-crypto PACs donating more than $40 million to his campaign. This narrow margin raises the question of whether a strong crypto voter base could sway the outcome.

The large donations have drawn criticism from those who see this influx of money as an effort by the crypto industry to shape policy for its benefit. According to Public Citizen’s research director Rick Claypool, the massive spending by crypto executives and firms is an overt attempt by a small sector to skew U.S. democracy to suit its profit-driven agenda. “The crypto industry’s massive investment has made it impossible to ignore its demand for less regulation and oversight,” he added.

As the elections unfold, the influence of crypto donations and their implications on policy continue to be closely observed, marking a pivotal moment for both the industry and American politics.

Now that Trump has been elected as the new POTUS, crypto industry actors like BitFuFu Inc. (NASDAQ: FUFU) are waiting to see if he will translate his campaign promises into policy actions that support the growth of the industry.

BitFuFu Inc. (FUFU), closed Friday's trading session at $4.68, off by 0.2132196%, on 113,970 volume. The average volume for the last 3 months is 1.252M and the stock's 52-week low/high is $2.32/$18.32.

Safe & Green Holdings Corp. (SGBX)

BUYINS.NET, StockMarketWatch, QualityStocks, MarketClub Analysis, InvestorPlace, Profitable Trader Authority, Buzz Stocks, HotOTC, InvestorsUnderground, OTCtipReporter, Penny Pick Finders, 360wallstreet, PennyStockScholar, TradersPro, Real Pennies, StockOnion, StreetInsider, The Online Investor, Tim Bohen, Timothy Sykes, TopPennyStockMovers and PennyStockProphet reported earlier on Safe & Green Holdings Corp. (SGBX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aegis Capital Corp. has been in the wealth management and investment banking business since 1984 and is dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. Today Aegis announced that it acted as exclusive placement agent on an approximately $2.4 million warrant inducement for Safe & Green Holdings Corp. (NASDAQ: SGBX).

To view the full press release, visit https://ibn.fm/XlSUi

About Safe & Green Holdings Corp.

Safe & Green Holdings designs and modifies code-engineered cargo shipping containers and purpose-built modules for commercial, industrial and residential building construction in the United States. It redesigns, repurposes and converts heavy-gauge steel cargo shipping containers into Safe & Green, which are green building blocks for construction. The company serves architects, landowners, builders, and developers. The company was formerly known as SG Blocks, Inc and changed its name to Safe & Green Holdings Corp. in December 2022. Safe & Green Holdings Corp. was founded in 2007 and is headquartered in Miami, Florida. For more information, visit www.SafeandGreenHoldings.com.

Safe & Green Holdings Corp. (SGBX), closed Friday's trading session at $0.6939, off by 10.9243%, on 769,590 volume. The average volume for the last 3 months is 71,410 and the stock's 52-week low/high is $0.6901/$27.00.

The QualityStocks Company Corner

HeartBeam Inc. (NASDAQ: BEAT)

The QualityStocks Daily Newsletter would like to spotlight HeartBeam Inc. (NASDAQ: BEAT) .

HeartBeam (NASDAQ: BEAT), reported steady progress in its third quarter financial and operational results, advancing its cardiac care technology through key FDA 510(k) submissions and strategic leadership appointments. The company's first FDA 510(k) submission for the HeartBeam system is actively under review, with HeartBeam responding to FDA inquiries and preparing for an Early Access Program post-clearance. Following this, HeartBeam plans to submit a second 510(k) application focused on its 12-lead ECG synthesis software. New CEO Robert Eno, along with other senior management hires, aims to guide the company toward U.S. commercialization. HeartBeam has also amassed significant clinical evidence supporting its innovative cardiac technology and recently garnered the "Rising Star" award in the Home Health Diagnostic Category at the Digital Health Hub Foundation Awards.

To view the full press release, visit https://ibn.fm/YGrBX

HeartBeam Inc. (NASDAQ: BEAT) is a cardiac technology company that has developed the first and only 3D-vector 12-lead electrocardiogram (ECG) platform for heart attack detection anytime, anywhere. The company’s proprietary ECG telehealth technology aims to redefine the way high risk cardiovascular patients are diagnosed in ambulatory and acute care settings. HeartBeam’s initial focus is on providing diagnostic data to help physicians with care management of patients with cardiovascular disease.

In August 2022, HeartBeam announced that it submitted its HeartBeam AIMI™ software for approval from the U.S. Food and Drug Administration (FDA). HeartBeam AIMI is a platform technology to improve the speed and accuracy of heart attack detection in acute care settings. The company expects FDA approval by the end of 2022, and a full commercial roll-out of HeartBeam AIMI is targeted for Q1 2023.

HeartBeam sees submission of its first product based on its platform technology as an important milestone toward commercialization, which underscores the company’s continued progress toward making the HeartBeam AIMI platform widely available to help emergency department physicians quickly and accurately identify a heart attack.

While the FDA conducts its regulatory review, HeartBeam will focus on executing key components of its commercialization plan and subscription revenue model. It will also continue to engage in discussions with strategic institutions, including academic centers, regional healthcare systems and regional community hospital systems that can utilize HeartBeam products.

The company is based in Santa Clara, California.

Products

HeartBeam’s development portfolio includes two products:

  • HeartBeam AIMI is software that provides a 3D comparison of baseline and symptomatic 12-lead ECG to more accurately identify a heart attack in acute care settings and, as noted above, has been submitted for FDA approval; and
  • HeartBeam AIMIGo™, the first and only credit card-sized 12-lead output ECG device coupled with a smartphone app and cloud-based diagnostic software system for remote heart attack detection.

HeartBeam is developing AIMIGo, a medical-grade detection and monitoring technology for use in remote heart attack detection, thereby allowing physicians to diagnose a patient’s heart attack as it occurs, even if the patient is not at a medical facility. The company’s system, once approved by the FDA, can be used by patients at home or almost anywhere and anytime to help their physicians assess whether chest pain is the result of a heart attack or another cause. While approximately 82% of chest pain ED visits are unnecessary, patients delay approximately 3 to 4 hours after symptoms begin, increasing mortality rates by 40%. The company’s goal is to shorten the time to treatment outside of the medical facility to improve patients’ well-being.

HeartBeam’s AIMIGo is a powerful, portable and easy-to-use prescription-based product. It comprises a smartphone app, a credit card-sized ECG device placed on a patient’s chest, the HeartBeam cloud platform, and a digital portal for the physician to view ECG results and direct patient action. For the first time outside of a medical setting, HeartBeam AIMIGo enables patients and their clinicians to determine if symptoms are due to a heart attack, quickly and easily, so care can be expedited, if needed.

Pending FDA clearance, AIMIGo is initially intended to be available by prescription, and is reimbursable under existing remote patient monitoring codes (RPM codes). This provides a new revenue stream to physicians who before did not have a way to monitor these high-risk patients. The RPM codes provide a monthly reoccurring revenue stream to the company, as well. On average, at current reimbursement rates, the practice will receive $1,300+ per year per patient they monitor, and the company will receive $600 per year per patient from this RPM reimbursement.

Market Overview

Adoption rates of telehealth services increased dramatically in recent years, with the COVID-19 pandemic serving as a major driver of growth. Among the areas seeing the greatest expansion are cardiology, radiology, behavioral health and online consultation.

Encouraging this growth, governments are actively developing new policies and reimbursement guidelines to promote the use of digital health platforms. The U.S. Centers for Medicare & Medicaid Services (CMS), for example, has recently expanded reimbursement for telehealth services. U.S. market growth is also being driven by the rising prevalence of chronic conditions and the growing geriatric population.

Remote heart attack detection is a previously unsolved problem with a massive and underserved market that is several times larger than the $2 billion total addressable market (TAM) in the U.S. for ECG cardiac arrhythmia monitoring.

Approximately 8 million Americans have suffered at least one heart attack, and a total of 18 million have been diagnosed with coronary artery disease (CAD). Based on these figures, HeartBeam projects a total addressable U.S. market TAM valued at $10 billion annually for its AIMIGo solution for remote heart attack monitoring of CAD.

Management Team

Branislav Vajdic, Ph.D., Chief Executive Officer and Founder of HeartBeam, Inc, combines over 30 years of experience in technology development and senior management positions. Dr. Vajdic has been deeply involved with the development of HeartBeam’s technology to fit his vision for the company. Prior to HeartBeam, from 2007 to 2010, Dr. Vajdic was CEO and Founder of NewCardio, a publicly traded company in the cardiovascular devices space. From 1984 to 2007, Dr. Vajdic was at Intel, where he held various senior management position. At Intel, Dr. Vajdic was the designer of first Flash memory and two key inventions that enabled Flash as a product and led engineering groups responsible for Pentium 1 through Pentium 4 designs. Dr. Vajdic was awarded two Intel Achievement Awards, the highest level of award for outstanding contributions to Intel. Dr. Vajdic is author of numerous patents and publications in the fields of cardiovascular devices, as well as chip design. Dr. Vajdic holds a Ph.D. in Electrical Engineering from the University of Minnesota.

Jon Hunt, Ph.D., has over 35 years’ experience in the medical/medical device industry with extensive domestic and international experience in general management, clinical/regulatory, sales and marketing. He also has diverse experience in Fortune 500 companies, as well as start-up environments. Dr. Hunt was the Vice President of Clinical Science and Technology, Medical Device Innovation Consortium, from July 2019 to July 2021, and Vice President of Clinical and Regulatory Affairs, Cryterion Medical from January 2018 to June 2019 (acquired by Boston Scientific Corporation in July 2018 for $202M). Dr. Hunt was the Founding President and CEO of Bardy Diagnostics, Inc. from October 2013 to November 2017 (acquired by Hill-Rom Holdings, Inc.). Prior to joining Bardy Diagnostics, Dr. Hunt spent the previous 11 years as the Vice President of Clinical & Regulatory Affairs with Cameron Health, Inc. (acquired by Boston Scientific Corporation). Dr. Hunt spent the previous 10 years with Cardiac Pacemakers, Inc., St. Jude Medical and Cardiac Pathways Corporation. Dr. Hunt began his career with Cardiac Pacemakers, Inc. (now Boston Scientific Corporation) as the Director of Clinical Programs. He subsequently held positions at St. Jude Medical in Clinical Affairs and as the Business Unit Director for the Cardiac Rhythm Management division for Europe, the Middle East and Africa. At Cardiac Pathways Corporation, Dr. Hunt held various executive positions as Vice President of International Sales and Marketing and Vice President of Worldwide Sales and Marketing (acquired by Boston Scientific Corporation). Dr. Hunt received his Ph.D. in Motor Control from The Pennsylvania State University, his Master’s from California State University, Long Beach and his undergraduate degree from Keele University in the United Kingdom.

Rick Brounstein, HeartBeam’s Chief Financial Officer, combines over 30 years of experience in health technology senior management. Since 2017, Mr. Brounstein has been and is currently a partner of Hardesty, LLC, a financial services firm, and Mr. Brounstein is currently a managing director of CTRLCFO, LLC, a firm Mr. Brounstein founded in 2016 to support funded start-ups in life science and technology. From 2008 to 2011, Mr. Brounstein was Chief Financial Officer of NewCardio, Inc., a microcap public company in the cardiology space, and, over his career, he has been with nine other companies in life science or technology, holding positions including Chief Financial Officer, Chief Operating Officer, Treasurer and Accounting Manager. From June 2001 through November 2007, Mr. Brounstein held several positions at Calypte Biomedical Corporation, a publicly traded medical device company, including Chief Financial Officer and Executive Vice President. In January 2007, Mr. Brounstein was appointed as the National Member Representative for the 2007 COSO Monitoring Project, which published new guidelines for monitoring internal financial controls in February 2009; Mr. Brounstein subsequently was a member of the FEI task force that issued the updated COSO Internal Control Framework in 2013. In March 2005, Mr. Brounstein was appointed to the SEC Advisory Committee on Smaller Public Companies. Mr. Brounstein earned his Certified Public Accountant (CPA) certification while working at Arthur Andersen LLP, formerly a public accounting firm. Mr. Brounstein holds a B.A. in accounting and an M.B.A. in finance, both from Michigan State University.

Ken Persen, HeartBeam’s Chief Technology Officer, combines over 28 years of experience in the medical device and digital health industries in engineering and senior management positions. Mr. Persen has been involved in several companies in Cardiac Rhythm Management, holding positions including Chief Executive Officer, Chief Technology Officer, Executive Vice President and Director of Engineering. Since 2016 and prior to joining HeartBeam, Mr. Persen was the Chief Technology Officer at LIVMOR, Inc., a digital health company. In addition, from 2016 through November 2021, he was also Chief Executive Officer of LIVMOR. Prior roles included Director of Engineering at Cameron Health (acquired by Boston Scientific), a late-stage medical device start up, and engineering and management positions at Guidant Corp. (acquired by Boston Scientific), a large medical device manufacturer. He has an undergraduate degree from University of Minnesota, Duluth, with a BA in Computer Science.

HeartBeam Inc. (NASDAQ: BEAT), closed Friday's trading session at $2.57, up 10.3004%, on 202,979 volume. The average volume for the last 3 months is 4.514M and the stock's 52-week low/high is $1.06/$3.3893.

Recent News

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

D-Wave Quantum Inc. (NYSE: QBTS) ("D-Wave") recently participated in the Quantum Technologies Forum hosted by the University of Southern California (USC), presenting the latest advancements in its annealing quantum computing technology. D-Wave's participation in the event highlights the company's ongoing partnership with USC, which was the first organization to host a D-Wave Advantage™ quantum system in the United States in 2022.

Through D-Wave's Leap™ quantum cloud service, USC's Viterbi School of Engineering has leveraged this 5,000+ qubit system—the largest of its kind—for pioneering research in areas such as protein binding classification and quantum coherence. The forum, which convened experts across academia, industry, and government, aims to further quantum research and establish Southern California as a hub for quantum technology development.

To view the full press release, visit https://ibn.fm/80lT5

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Friday's trading session at $1.6, up 9.589%, on 16,819,440 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $3.3893/$.

Recent News

CNS Pharmaceuticals Inc. (NASDAQ: CNSP)

The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

Researchers have developed a chip that may revolutionize how brain cancer is treated. This revolutionary device is made of graphene, a material made of pure carbon that's over a hundred times stronger than steel. Graphene is extracted from graphite and was invented two decades ago by Konstantin Novoselov and Andre Geim. Novoselov and Geim, both Manchester University researchers, won the 2010 Nobel Prize in physics for their work. The flexible chip is the size of a postage stamp and has been dubbed the brain-computer interface device. It was designed to identify cancer cells based on their electrical emissions, which differ from those of healthy tissue. The Manchester professor adds that this technology may also give rise to a new understanding about how brain cells interact in a diseased state and function. With entities like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) also advancing innovative therapeutics for brain cancers, anticipation is building around multiple new potential treatment options.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.

The company was founded in 2017 and is headquartered in Houston, Texas.

Organ Targeted Therapeutics

The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.

CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.

CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.

CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.

CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.

The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.

CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.

Global Brain Tumor Therapeutics Market

The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.

A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.

Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.

Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.

One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (http://nnw.fm/eDUjp).

Management Team

John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.

Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.

Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.

Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Friday's trading session at $0.1168, up 3.2714%, on 8,097,369 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0955/$6875.00.

Recent News

Horizon Fintex | Upstream

The QualityStocks Daily Newsletter would like to spotlight Horizon Fintex | Upstream

Upstream, a MERJ Exchange market and trading app, published a blog today that discussed the move to expand its trading to 20 hours per day, 7 days per week (10:00 a.m. to 06:00 a.m. UTC+4). As a result, non-U.S. investors can use the expanded trading window to buy and sell listed U.S. and international equities in real-time directly through the Upstream trading app. The blockchain-powered expansion works to offer convenient stock trading for issuers and investors around the world.

"Upstream enables issuers listed on any major stock exchange to dual list and reach international investors who can buy and trade their shares right from their phones," said Brian Collins, Horizon president and Upstream co-creator. "Expanding our trading hours to near 24/7 trading creates unprecedented opportunity for traders across borders and time zones… This breakthrough in access gives investors around-the-clock opportunities to react to market changes in real-time, even when traditional markets are closed. This enhanced accessibility empowers our users to maximize their investment potential and stay ahead of the curve."

To view the full blog, visit https://ibn.fm/in8lK

Horizon Fintex is a software business specializing in compliant securities solutions. The company aims to facilitate the future of capital markets by leveraging the regulatory experience of Wall Street bankers and the proven track record of technology veterans to bring focus to compliance, efficiency, security and transparency.

Horizon’s flagship product is the revolutionary trading app ‘Upstream’, a MERJ Exchange Market, and the first regulated market powered by a blockchain to offer both digital securities and NFT trading. Upstream traders experience T+0 settlement, best bids and offers displayed on a transparent public orderbook that prevents predatory market practices – all from a user-friendly trading app.

Products

Horizon Fintex offers a full suite of end-to-end blockchain-enhanced software solutions to create a seamless experience for both issuers and investors. Its product suite includes:

  • Securitization & IssuanceETSware is an end-to-end Electronic Trading System streamlining capital raising from primary issuance through compliant secondary trading.
  • KYC Compliance OnboardingKYCware is a white label Know Your Customer (KYC) and Anti-Money Laundering (AML) compliance software solution offering best-in-class cryptographic security to compliantly onboard and verify user identity through a smartphone application.
  • AML Screening SoftwareAMLCop offers advanced Anti-Money Laundering (AML) software to streamline the verification of user details against a proprietary database of global sanctions, politically exposed persons (PEPs) and watchlists.
  • Cap. Table Management ToolsCustodyWare equips registered U.S. transfer agents with next-generation cap. table management software to manage securities on behalf of their clients pursuant to an SEC-registered or exempt securities offering.
  • Exchange & Trading App TechnologyOpen Order Book offers Ethereum blockchain securities exchange software to power the next generation of trading venues for digital assets.

Upstream – The Horizon-Powered Trading App

Upstream is a joint venture with MERJ Exchange (merj.exchange), an affiliate of the World Federation of Exchanges.

Upstream aims to be the premiere global trading hub offering issuers around the world exposure to a digital-first investor base that can trade using USDC digital currency along with credit, debit, PayPal, and USD (fiat) to increase liquidity and enhance price discovery; while also offering investors access to dual-listed companies, IPOs, crowdfunded companies, U.S. & Int’l. equities, digital coupons and NFTs directly from a user-friendly trading app.

Upstream aims to unlock liquidity for investors of all levels while offering industry-leading levels of transparency, accessibility and investor protections enforced using Ethereum blockchain technology.

Management Team

Brian Collins is the CEO of Horizon Fintex. He founded the company in 2010. From 1999-2010, Mr. Collins was CEO of Abbey Technology in Switzerland, specializing in the design of trading software for Swiss banks. Prior to this, he worked for Credit Suisse in Zürich, designing and building proprietary equity trading solutions. Mr. Collins graduated in 1990 with a BS in Computer Systems from the University of Limerick, Ireland.

Mark Elenowitz is the company’s President. He is a Wall Street veteran with over 29 years of experience. Mr. Elenowitz was the co-founder of a U.S. broker dealer and is Managing Director of two U.S. broker dealers, responsible for advising clients on compliance, capital structure and capital market navigation. He was responsible for leading the first successful Reg A+ IPO of a company to list on the NYSE and others which listed directly onto Nasdaq. He is a noted speaker at Small Cap and Reg A events, including the SEC Small Business Forum, and has been profiled in BusinessWeek and CNBC, as well as several other publications. Mr. Elenowitz is a graduate of the University of Maryland School of Business and Management with a BS in Finance and holds Series 24, 62, 63, 79, 82 and 99 licenses.

Dr. Andrew Le Gear is the CTO of Horizon Fintex. Prior to joining the company in 2013, he worked as a software engineer with Dell Inc. (2012-2013) and Lehman Brothers and Nomura Plc. (2007-2012). Dr. Le Gear was a co-founder of Juneberi Ltd., a research-driven software tech start-up (2004-2007). He graduated in 2006 with a Ph.D. in Computer Science from the University of Limerick, Ireland.

Peter Hall is the company’s CIO. Prior to joining Horizon Fintex in 2011, he worked at Microsoft (2008-2011), Atos Origin (2004-2008) and AIT Group Plc. (1998-2002). Mr. Hall has held CISSP certification since 2010. He graduated from the University of Sheffield, UK in 1995 and earned an MS from the University College London in 2006.

Mike Boswell is the CFO of Horizon Fintex. A Wall Street veteran, he co-founded a U.S. broker dealer and served as Chief Compliance Officer. Mr. Boswell was also Managing Director of TriPoint Capital Advisors, a merchant banking and financial consulting company, and CFO of Mission Solutions Group, a privately held defense sector firm. He earned an MBA from John Hopkins University and a BS in Mechanical Engineering from the University of Maryland. Mr. Boswell holds Series 24, 62, 63, 79, 82 and 99 licenses.

Recent News

chart

Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF)

The QualityStocks Daily Newsletter would like to spotlightFathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF).

With more and more countries working to reduce emissions globally, the demand for metals and minerals required for clean energy tech has increased significantly. While current demand can be met, the harming of local environments and strain experienced by existing supply chains may soon affect the supply of these critical minerals. New research has looked into whether nickel can be produced in a sustainable way. The research was conducted by a team of 12 researchers, including Prof. Elsa OlivettiKaran Bhuwalka and Basuhi Ravi, who recently graduated with PhDs. In their conclusion, the researchers added that favoring projects which met high social and environmental standards and the use of responsible investment practices by global financial institutions could also contribute to a sustainable and stable nickel supply chain. Many extractive industry players like Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) are investing efforts to address many of the concerns about the process of exploring for and mining nickel. There is hope that the concerns these researchers point out could gradually be eliminated during nickel mining and processing operations.

Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) is a Canadian natural resource development and exploration company that targets high-grade nickel sulfide discoveries for use in the rapidly growing global electric vehicle (EV) market. The company has a portfolio of two high-quality exploration projects located in the prolific Trans Hudson Corridor in Saskatchewan.

Led by a management team with more than 100 years of combined mining and exploration experience, Fathom believes in a continuing bright outlook for nickel and its increasing use in the manufacturing of batteries needed for energy storage in the high-growth renewable energy and EV industries. The company’s modern approach to exploration has yielded significant new nickel discoveries.

Fathom is headquartered in Calgary, Alberta.

Projects

The Albert Lake Project

The Albert Lake Project comprises 90,460 hectares of lands located in north-central Saskatchewan, with over 80,000 hectares currently unexplored. The project is host to the historic Rottenstone Mine, a high-grade, open pit nickel sulfide past producer that was active from 1965 to 1969 and yielded ~26,000 tonnes of 3.3% Ni, 1.8% Cu, and >9 g/t Pd-Pt+Au.

The geological setting of the Albert Lake Project is within the Trans Hudson Orogeny (Corridor), which is host to numerous world-class nickel mining camps including the Thompson Nickel Belt (currently operating with more than 5 billion pounds of nickel produced since 1959), Lynn Lake (past producer) and Raglan Nickel Belt (currently operating with more than 39,000 tons of nickel produced in 2020).

The project is fully permitted. Exploration plans for 2024 include drilling a high-priority target located approximately 2km south of the historic Rottenstone Mine along with drilling other high-priority targets. Additional soil geochemistry, surface geophysical programs and geological mapping and prospecting will be performed during the summer field season.

The Gochager Lake Project

The Gochager Lake Project in northern Saskatchewan, also in the prolific Trans Hudson Corridor, was recently expanded through the addition of the contiguous Watt’s Lake property and direct staking, bringing its total land area to 22,620 hectares.

The Gochager Lake property is host to a historic resource defined by drilling in 1966-1967 consisting of 4.2 M tons grading 0.29% Ni and 0.08% Cu. Recent drilling by Fathom has defined multiple very robust off-hole borehole electromagnetic (BHEM) responses in eight of nine holes drilled in 2023 and three historic drill holes probed. There is very strong evidence of multiple, high-grade nickel-copper-cobalt steeply oriented chutes within the historic Gochager Lake Deposit.

Prior to Fathom exploration in 2023 and since 1970, exploration at the property has been limited to small drill programs in 1989-1990 and 2018. Exploration plans for 2024 include expanded surface geophysical programs, drilling and continued BHEM surveys to expand tons and increase the grade of the historic Gochager Lake deposit. Summer exploration will consist of soil geochemistry, mapping, prospecting and additional surface geophysical programs focused on identifying other Gochager-like deposits within the current land package.

Market Opportunity

Nickel plays a crucial role in clean energy technologies, and that is expected to cause demand to well outstrip supply for the foreseeable future.

With an annual market value of around $35 billion, nickel demand is projected to rise due to its intensive use in lithium-ion batteries used to power EVs. However, new discoveries of nickel sulfide deposits (currently the most reliable source for battery-grade class 1 nickel) have been rare, which could constrain class 1 nickel supply in the coming years.

According to Deloitte’s global EV forecast, total EV sales will grow from 2.5 million in 2020 to 11.2 million in 2025, reaching 31.1 million by 2030 and representing approximately 32% of the total market share for new car sales. Over the next 10 years, the EV market is projected to see a CAGR of 29%, with increased demand for nickel expected to be comparable.

Management Team

Fathom Nickel has assembled a best-in-class leadership team consisting of highly qualified industry professionals with deep knowledge and understanding of the mineral exploration industry and capital markets.

Ian Fraser, P.Geo., is CEO, VP Exploration and Co-Founder of Fathom Nickel. He has more than 35 years of experience in mineral exploration, as well as managing and implementing exploration projects in Canada and internationally. His experience includes resource interpretation and development of the Casa Berardi Gold Mine and Komis Gold Mine, as well as the Cisneros Gold Mine in Colombia.

Doug Porter, CPA, CA, CBV, is President, CFO and Director of Fathom Nickel. He is a senior financial and accounting executive with specific emphasis in resource company management. His career includes positions with Elan Coal Ltd., Altitude Resources Ltd. and StimWrx Oilfield Services Ltd.

Fathom Nickel Inc. (OTCQB: FNICF), closed Friday's trading session at $0.024, even for the day, on 233,000 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.013465/$0.1603.

Recent News

Cepton Inc. (NASDAQ: CPTN)

The QualityStocks Daily Newsletter would like to spotlight Cepton Inc. (NASDAQ: CPTN).

Cepton (NASDAQ: CPTN) shared updates for Q3 2024, highlighting advancements in its lidar technology commercialization, with a major long-range lidar RFQ in final stages with a Top 10 global automotive OEM. Cepton's CEO, Jun Pei, noted the company's solid positioning in the automotive lidar market, strengthened by a pending acquisition by Koito Manufacturing Co. Ltd. and continued development with OEMs for near-range lidar. The acquisition, set at $3.17 per share in an all-cash transaction, is anticipated to close in early 2025, subject to shareholder and regulatory approvals. For Q3, Cepton reported $0.5 million in revenue, with a GAAP net loss of $10.6 million and an adjusted EBITDA of $(8.0) million.

To view the full press release, visit https://ibn.fm/GPnjt

Cepton Inc. (NASDAQ: CPTN) is a provider of state-of-the-art, intelligent, lidar-based solutions serving a range of markets, including automotive (ADAS/AV), smart cities, smart spaces and smart industrial applications. General Motors (NYSE:GM) has granted a series production award for Cepton’s lidar, the biggest such award to date in the automotive space. Cepton’s is the lidar component of GM’s Ultra Cruise autonomous driving platform. By leveraging its patented Micro Motion Technology (MMT®) lidar platform, the company develops reliable, scalable and cost-effective solutions that deliver long-range, high-resolution 3D perception for smart applications.

Cepton was established in 2016 by co-founders Dr. Jun Pei and Dr. Mark McCord. The company is headquartered in San Jose, California, and serves a fast-growing customer base through an international presence spanning North America, Germany, Japan, India and China.

Micro Motion Technology (MMT®)

Cepton was built from the ground up to meet key lidar industry challenges for mass market adoption. This company’s portfolio of proprietary technology is uniquely aimed at facilitating this industry growth through a combination of performance, reliability, affordability and design integration.

Key among its innovations is MMT®, a mirrorless, frictionless, rotation-free 3D imaging platform designed specifically for lidars. Its benefits for OEMs and system integrators include:

  • Reliability – The durable design uses common, easily attainable materials.
  • Versatility – The platform is capable of achieving near- to ultra-long range with a wide field of view.
  • Efficiency – MMT® features a compact form factor, low power usage and inexpensive components.
  • Scalability – Its simple design means that scale-up to high manufacturing volumes is easily attainable.

Because of their compact form factor, Cepton lidars are embeddable and ideally suited for advanced driver-assistance system (ADAS) integration, whether behind windshield, in headlamp or in fascia.

Agreement with KOITO

KOITO Manufacturing Co. Ltd., the world’s premier Tier 1 auto lighting supplier, originally started an evaluation of Cepton’s MMT® based lidars in 2018. In 2020, KOITO made an investment in Cepton aimed at accelerating the company’s development and enabling KOITO’s industrialization of high-performance and high reliability lidar sensors for ADAS and autonomous vehicle (AV) applications.

Through this collaboration, Cepton was able to secure the largest ADAS lidar series production award[1] with General Motors as a sole source in the automotive space. The award covers GM vehicles for the initial period of 2023-2027.

On August 5, 2021, the two companies deepened their relationship when KOITO committed to invest a further $50 million in Cepton’s business through its participation in a Private Investment in Public Equity (PIPE) offering of shares of common stock of Growth Capital Acquisition Corp. in connection with Cepton’s recent merger.

Collaboration with GM

On July 13, 2021, Cepton announced that it had secured an ADAS lidar series production award from a leading, Detroit-based global automotive OEM – the biggest lidar production award by any OEM to any lidar company. It was later clarified that the OEM was General Motors, and Cepton’s lidar is part of GM’s ADAS Ultra Cruise system.

GM is “expected to deploy Cepton lidars in its next generation of advanced driver assistance systems (ADAS) across multiple vehicle classes and models – not just luxury cars.” As such, the agreement marks the potential for “an industry-first, mass-market adoption of lidar technology for automotive ADAS, with an anticipated deployment in consumer vehicles starting in 2023.”

On July 28, 2021, Ford Motor Company (NYSE: F) distributed an article on Medium noting, “Ford has been engaged with Cepton almost since their inception in 2016, both for R&D collaboration and small-scale deployments. Cepton LiDAR are deployed in some of [Ford’s] smart city projects. Based on Ford’s guidance, Cepton delivered a custom version of their LiDAR to enable R&D on advanced ADAS features.”

Market Outlook

Driven by increasing development and adoption in automobile safety applications, environmental mapping and 3D-modeling, the global lidar market is forecast to experience considerable growth over the coming years. A research report published by MarketsAndMarkets suggests that the sector will grow to an estimated $3.4 billion by 2026, achieving a CAGR of 21.6% over the next five years.

The report further highlights increasing investments in lidar startups by automotive giants as a driver of growth opportunities in the sector, particularly in North America.

In 2020, ground-based lidar accounted for the lion’s share of the overall lidar market, and this trend is expected to continue as the automotive sector continues to rapidly advance adoption across the full spectrum of vehicle classes. One factor not to be underestimated is the high barrier of entry and the exceptionally long time required for automotive OEMs to vet and award a production win to a lidar company. It is a commonly held view that the over 50 lidar companies will inevitably coalesce into a handful serving all OEMs.

Cepton, having a head start through its established partnership with leading global OEM GM, is uniquely positioned to capitalize on this market growth in the years to come.

Management Team

Cepton’s founder-led team is made up of lidar industry pioneers with decades of collective experience across advanced lidar and imaging technologies.

Jun Pei, Ph.D., is the company’s CEO and Co-Founder. He is a technology specialist with a focus in optics and electronics. Prior to founding Cepton, Dr. Pei founded AEP Technology, a firm focused on developing advanced 3D optical instruments. He received his Ph.D. in electrical engineering from Stanford University.

Mark McCord, Ph.D., is Cepton’s CTO and Co-Founder. Prior to founding Cepton, he led advanced development at KLA-Tencor. Dr. McCord also formerly served as an associate professor at Stanford University, where he earned his Ph.D. in electrical engineering.

Winston Fu, Ph.D., is the company’s CFO. Dr. Fu is the founder of Silicon Valley venture capital firm LDV Partners. Prior to joining Cepton, he served as CFO and Chairman of Active-Semi before its acquisition. Dr. Fu has also helped to build many technology companies as an entrepreneur and/or board member. He received his Ph.D. in applied physics from Stanford University, as well as an MBA from the Kellogg School of Management at Northwestern University.

[1] Largest known ADAS lidar series production award based on number of vehicle models awarded

Cepton Inc. (NASDAQ: CPTN), closed Friday's trading session at $3.12, off by 0.7949126%, on 5,892 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $2.38/$5.1999.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Intermittency is one of the key challenges governments will have to overcome as they build modern energy systems that are fully reliant on renewable energy. While fossil fuel-fired power plants generate energy at any time of the day or night, clean energy is dependent on the time and weather conditions. This is clean energy intermittency. A solar energy plant has zero output at night and its capacity may be limited during the day due to cloudy or overcast conditions. Renewables can produce energy in abundance but their intermittency can inject a lot of volatility into green energy prices, especially if they aren't paired with energy storage facilities. Intermittency will be a significant hurdle for nations to deal with as decarbonization becomes increasingly urgent and net-zero emission targets approach. EU Power Origination head Jean-Louis Malone outlines several ways players in the burgeoning green energy space can mitigate intermittency risks. The banks would outline hedging solutions such as energy storage for solar (which has the highest intermittency-induced volatility) that generate revenue from the green energy market's intraday volatility. Such storage centers would store excess energy when prices are low and then sell it back to the grid when energy prices are high, allowing investors to benefit from intraday volatility in the solar energy market. As the challenges of clean energy intermittency are addressed, electric vehicles from companies like Mullen Automotive Inc. (NASDAQ: MULN) that seek to reduce the eco-impact of vehicular transport will deliver greater benefits once the energy used to charge them is renewable and available round the clock.

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Friday's trading session at $1.65, off by 6.25%, on 1,218,438 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.60/$2797.00.

Recent News

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF)

The QualityStocks Daily Newsletter would like to spotlightFathom Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF).

The U.S. presidential election is done and dusted, and voters had their say regarding who they wish to head the next federal administration. The decision on whether Donald Trump will return to the Oval Office or Vice President Kamala Harris will become America's next president has been made. That decision has a huge bearing on how America will handle issues like ESG, sustainability and climate change. Both presidential candidates agreed that oil and gas production in America should be increased, to a certain degree. They also agreed that nuclear energy infrastructure needs extra support, but apart from that, they held very different views on the other aforementioned issues. Experts expect that the incoming Trump presidency would also impact the transport and clean energy markets, as well as sustainable finance. The Senate and the House being controlled by Republicans would only worsen this, with the oil and gas sector being the sole sector that'd receive support from this camp. Now that Trump is the President-elect, different companies like Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) will be watching for any policy pronouncements he makes that could have a major impact on their projections and operations.

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) is a publicly traded Canadian minerals exploration company focused on exploring high-grade copper and gold deposits in North America. The company owns the Storm Copper Project and the Seal Zinc Deposit in Nunavut, Canada, and is currently exploring the Buckingham Gold Vein and critical metals prospects in central Virginia. Aston Bay is also in the advanced stages of negotiation on other properties with high-grade critical minerals potential in these areas.

The company believes in responsible exploration and carries out its work programs to the highest standards of social responsibility, environmental stewardship and health and safety. Aston Bay cares about leaving a net positive impact on the communities in which it works and engages with local representatives, Indigenous groups and government agencies to build respectful relationships through dialogue and collaborative processes. Depending on the stage of exploration, these efforts may include employment, contracting, training, community benefits and other agreements.

Aston Bay conducts exploration through safe, socially and environmentally responsible and sustainable work practices. The company embeds core values of health and safety throughout its operations by adhering to strict health and safety standards and practices that meet and/or exceed industry standards and government codes and regulations.

The company is headquartered in Toronto.

Projects

Storm Copper

The high-grade Storm Copper Deposit is located 112 kilometers south of the community of Resolute Bay, Nunavut, on western Somerset Island, just south of the past-producing Polaris Pb-Zn Mine. The property comprises 173 contiguous mining claims, including the Storm Copper and Seal Zinc projects, covering an area of approximately 541,795 acres.

The property has good access to established shipping lanes, and the landscape provides favorable conditions for development of roads and a protected deep-water port. Exploration is supported through excellent infrastructure in the nearby hamlet of Resolute Bay.

Aston Bay is partnered with American West Metals (ASX: AW1) at Storm. American West is responsible for all exploration expenditures, having aggressively advanced the project toward production and earned an 80% interest. This affords excellent optionality to the company’s shareholders, as Aston Bay is free carried with no required expenditures until the completion of a bankable feasibility study.

American West recently completed an Australian JORC-compliant Maiden Resource Estimate for Storm; the North American 43-101 compliant resource estimate is expected in Q1 2024. American West is cashed up and plans a multimillion-dollar resource expansion and new discovery drilling program for the summer of 2024.

The Buckingham County Gold Project

The gold-bearing system at the Buckingham County Gold Project in Virginia lies within a belt hosting past producing mines, current gold mines and advanced gold explorations, stretching through Georgia, the Carolinas, Virginia, Nova Scotia and Newfoundland.

Buckingham hosts a “Kirkland Lake-style” high grade gold vein returning values consistently over one ounce gold per ton and is underexplored both at depth and along almost one mile of strike length. These types of veins have excellent ESG qualities, as they are typically mined using a small footprint underground method, with gold extracted using simple and environmentally friendly gravity methods.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion. The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth.

This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

A report from Acumen Research and Consulting, a global provider of market intelligence and consulting services, valued the global copper market at $304.1 billion in 2022 and forecast that it will reach a market size of $496.8 billion by 2032, growing at a CAGR of 5.1% over the forecast period.

The report identifies a growing demand for copper in the electronics industry, as well as an expanding copper supply due to increasing production from existing mines and the rising number of mine development projects in developing nations, as driving factors in the rising value of the copper market.

Management Team

Thomas Ullrich is CEO and Director of Aston Bay. He has over 30 years of experience in mineral exploration and geoscience. Before joining Aston Bay, he was Chief Geologist North America for Antofagasta Minerals plc, investigating copper potential through extensive property evaluations and management of drill programs in the United States, Mexico and Canada. Prior to that, he was Senior Geologist for Almaden Minerals.

Sofia Harquail handles Investor Relations and Corporate Development at Aston Bay. She has over 15 years of experience in the private and public sectors of the mining industry. Before joining Aston Bay, she worked as a consultant for the Prospectors and Developers Association of Canada and for exempt market dealer Red Cloud Financial Services Inc. Ms. Harquail holds an M.A. from the University of Uppsala in Sweden and received her CPIR designation from the CIRI/Ivey Investor Relations Program. She also sits on the board of the Young Mining Professionals Toronto and is CSC Certified.

Aston Bay has a talented Board of Directors bringing broad experience from across the industry, encompassing resource expansion, mine development, mergers and acquisitions, and mining finance.

Ms. Jessie Liu-Ernsting has over 15 years of experience in the mining industry, spanning capital projects engineering, debt capital markets, private equity and corporate strategy at several firms, including Hudbay Minerals and Resource Capital Funds. She is currently VP Investor Relations and Communications at G Mining Ventures Corp.

Mr. Jeffrey R. Wilson has over 25 years’ experience in the mining industry, having served as a director, officer and advisor of multiple public and private companies in the mineral exploration and mining investment industries. Mr. Wilson is currently President & CEO of Precipitate Gold Corp.

Mr. Gary O’Connor has over 40 years of diverse experience as a mineral exploration and development professional in the management of successful resource projects as well as the evaluation, technical due diligence, and supervision of large mineral exploration and development projects through-out the world. While with Freeport, Mr. O’Connor worked on the due diligence and discovery of a major gold fraud on the Busang gold “deposit” in Kalimantan by Bre-X.

Mr. Mark J. Pryor is a geologist with a 40-year track record of successfully advancing multiple precious metal, copper, coal, REE and Li projects from discovery through to exploitation. He is currently Executive Vice President of the Exploration Division at The Electrum Group.

Aston Bay Holdings Ltd. (OTCQB: ATBHF), closed Friday's trading session at $0.0611, off by 9.4815%, on 54,990 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0364/$0.1164.

Recent News

Software Effective Solutions Corp. (OTC: SFWJ)

The QualityStocks Daily Newsletter would like to spotlight Software Effective Solutions Corp. (OTC: SFWJ).

A recently conducted analysis has determined that workers in the hospitality and food service industries are some of the most common consumers of marijuana. Workers in extraction and construction, as well as individuals in media, sports, entertainment, arts and design occupations also reported relatively high rates of past-month marijuana use. The analysis was conducted by investigators at the Centers for Disease Control and Prevention and is based on data from the agency's Behavioral Risk Factor Surveillance System. This survey, which primarily focuses on behaviors and health conditions, started collecting data from respondents about their occupation status and employment in 2013. With regard to public policy, the investigators highlight that their findings may help decrease the adverse impact of marijuana consumption and possibly have implications for drug policies in the workplace. They note that their results could be used to frame future research and policy discussions. The peer-reviewed results were published in the American Journal of Public Health. As more information becomes known about the specific groups that are most likely to use recreational marijuana, enterprises like Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) could leverage that information to make customized products for those groups.

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) is a global infrastructure and holding company in the cannabis industry. MedCana currently has five companies focused on pharmaceutical cannabis production, as well a software company focused on managing processes for plant-to-patient operations. The recent acquisition of an irrigation and greenhouse technology company has rounded out MedCana’s portfolio of holdings.

MedCana’s focus is on developing clients and companies in Latin America, initially in Colombia, and partnerships with laboratories, research facilities and hospitals throughout the world. MedCana is building the technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts to the world.

MedCana’s goal is to be the world’s premier resource for pharmaceutical cannabis products. The company believes its advantage is its global view and reach. From initial cultivation to final product, MedCana aims to help partners produce pharmaceutical CBD and other extracts that will have no equal.

The company’s mission is to utilize its technology to partner with and develop companies that provide premium pharmaceutical-grade cannabis extracts with absolute integrity, sustainability and social responsibility. MedCana’s team of pharmaceutical scientists includes some of the most respected chemists in the world. They aim to ensure that the company’s customers and partners create premium cannabis extracts that meet the growing worldwide demand. MedCana’s software is designed to ensure traceability and quality from seed to finished product.

MedCana is headquartered in Austin, Texas, with offices in Colombia.

Production

MedCana announced in May 2023 the beginning of full-scale production of non-THC cannabis for export to Europe in response to high demand in that market. This expansion comes after the successful completion of full crop cycle testing and infrastructure development at production sites in Columbia.

The recent acquisition of the assets of Tokan Corp., a software company focused on creating an enterprise resource planning (ERP) platform for the cannabis industry, and Eko2O S.A.S., a greenhouse and irrigation engineering company, has positioned MedCana for explosive growth in the region.

As a MedCana subsidiary, Eko2O SA will increase the company’s revenue potential in Central and South America. The subsidiary specializes in the construction and distribution of greenhouses and sophisticated irrigation platforms. A positive outlook has resulted from the company’s expansion as it investigates new opportunities for greenhouse and irrigation system installations in Panama and Uruguay. These opportunities are expected to accelerate Eko2O’s development and strengthen its position as a top supplier of innovative agricultural solutions in cannabis and other sectors that are quickly moving to high technology agricultural production.

In addition, MedCana has started talks with the government in Argentina about possible incentives for beginning operations in that country as part of its ongoing worldwide development strategy. Support from the Argentinean government and the start of new operations there would greatly increase MedCana’s market share in Latin America and solidify the company’s position as the market leader in the cannabis industry.

Market Opportunity

According to a report by Grand View Research, a San Francisco-based market research and consulting company, the global cannabis extract market was valued at $3.5 billion in 2022 and is expected to expand at a CAGR of 20% from 2023 to 2030 to be worth more than $15 billion.

Growing demand for cannabis extracts, including oils and tinctures, and the increased legalization of marijuana for the treatment of different chronic ailments like arthritis, Alzheimer’s, anxiety and cancer are driving the expansion of the industry. The marijuana derivative industry is flourishing due to a greater understanding of its various medical benefits.

Management Team

Jose Gabriel Diaz is CEO of MedCana. He has successfully built, grown and sold multiple telecom companies. He was senior vice president of sales at IP Communications, a national high-speed data provider. He also founded Reallinx, a national data carrier later sold to GTT Communications. Additionally, he is currently president of the A.E.M. Business and Entrepreneurship Association in Austin, Texas.

Claudio Jiménez Cartagena, QF, Ph.D. is Chief Scientific Officer at MedCana. He joined MedCana after working with Sosteli Pharma as Technical Director and serving as a director consultant for the Corporation for Agricultural Industrial Development at the University of Antioquia in Colombia. Before that, he worked as the scientific director at the Institute of Food Science & Technology. He holds a bachelor’s degree in pharmaceutical chemistry, a master’s degree in basic biomedical sciences and a doctoral degree in Environmental Engineering from the University of Antioquia.

Julián Alberto Londoño Londoño, Ph.D., is Senior Vice President of Operations at MedCana. He previously served as general manager for the Corporation for Agricultural Industrial Development, and as Chief Scientific Officer at Sosteli Pharma in the Resource Management Department. He has developed multiple U.S. patents, and recently served as senior advisor to the Secretariat of Agriculture Development for the Government of Antioquia. He holds a doctorate in Chemical Sciences from the University of Antioquia.

Software Effective Solutions Corp. (OTC: SFWJ), closed Friday's trading session at $0.02675, off by 10.8333%, on 16,200 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.000001/$0.09.

Recent News

Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF)

The QualityStocks Daily Newsletter would like to spotlight Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF).

Green metals play a pivotal role in promoting sustainability due to their critical use in clean-energy technologies.

Renforth Resources is well positioned to contribute to the green-metals supply through its Quebec-based Malartic Metals Package.

The company's exploration efforts on the Malartic Metals Package reflect a commitment to advancing the green-metals supply in an environmentally conscious way.

In a world that's increasingly focused on sustainability, "green metals" have emerged as vital materials for building an environmentally friendly future. Green metals, including nickel, zinc, copper and cobalt, are essential for developing sustainable technologies and supporting the transition away from fossil fuels. These metals are crucial for renewable energy systems, electric vehicles and energy-efficient infrastructure, all of which are integral to reducing carbon emissions and mitigating climate change. As demand for green metals continues to rise, companies such as Renforth Resources (CSE: RFR) (OTCQB: RFHRF) are positioning themselves to become leading providers of these essential materials, bolstering the shift toward a greener economy.

Annovis Bio Inc. Overview

Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) is an active mineral exploration company engaged in the exploration and development of the company’s wholly owned multi-commodity mineral properties in Canada. The company owns the Parbec gold deposit on the Cadillac Break in Quebec and is currently exploring the Parbec property to increase the gold resource and identify a location to strip and bulk sample from surface.

In addition, the company holds the Nixon Bartleman gold property in Ontario and is also engaged in developing its wholly owned Malartic Metals Package, Quebec’s newest polymetallic battery minerals district with several areas of mineralization, one of which is the nickel, cobalt, copper and zinc mineralized Victoria structure boasting approximately 20 kilometers of strike with surface mineralization, limited drilling, road access and hydroelectric power.

Renforth is well positioned in the heart of the Abitibi Greenstone belt, which straddles the Canadian Provinces of Ontario and Quebec, on both of the Cadillac-Larder Lake and Destor-Porcupine faults – the two main structures responsible for a belt endowed with more than 300 million ounces of gold (including production, M&I reserves and resources to date), making it one of the world’s most prospective gold regions.

The Canadian Malartic Mine, one of Canada’s largest gold mines, is adjacent to each of Renforth’s brownfield Malartic area properties, the Parbec open pit gold resource and the Malartic Metals Package, which, in addition to several known battery metals mineralized structures, also hosts gold within the Pontiac sediments, a very under-explored geological setting.

The company is headquartered in Pickering, Ontario.

Projects

Parbec Gold Deposit

Renforth’s 100% owned Parbec Gold Deposit contains a gold resource designed with an open pit to capitalize on Parbec’s surface mineralization. An MRE on the project, effective December 2019 and now considered by Renforth to be obsolete, is based upon approximately 28,000 meters of drilling which occurred between 2007 and 2019.

Renforth drilled 15,000 meters of new holes in 2020 and 2021 which were not included in the MRE, but which did extend the mineralization deeper within the MRE. The 2020-21 drilling is considered to have validated an additional 13,000 meters of historic drilling from 1986-93.

The validation occurs as 10% of the historic holes were redrilled, with results comparable to the historic results in terms of geology and gold values. Any future MRE calculated at Parbec will benefit from the inclusion of the new and historic drilling.

In addition to this, Renforth’s current structural interpretation on the location of, and controls on, the gold mineralization at Parbec is materially different than the geological model for the outdated MRE. For the first time, Renforth has mapped the Pontiac contact and interpreted a hinge fold interacting with the Cadillac Break and allowing the movement of gold enriched fluids, with mineralization plunging to the south, into the Pontiac.

It is worth noting that a structural control on the adjacent, and much larger, Canadian Malartic Mine is the Sladen Fault transiting into the Pontiac. Currently, Renforth is testing this interpretation with a soil survey designed to outline an area for stripping and bulk sampling within the Pontiac south of the Cadillac Break.

Malartic Metals Package

Renforth’s wholly owned approximately 300-square-kilometer Malartic Metals Package in Quebec’s mining heartland includes surface mineralization of battery metals nickel, cobalt, copper, zinc and silver in separate structures, as well as a copper/silver discovery and gold mineralization. Lithium is also present in anomalous amounts in the sediments, though the source has not yet been located.

The property was assembled commencing in 2020 by adding claims to Renforth’s existing Malartic West property by map staking. The goal was to acquire historic gold and base metal showings, as well as pronounced magnetic anomalies, joining several of the areas of discrete historic exploration into a district scale property with several areas of interest for battery metals and a greenfield copper/silver discovery. The property benefits from its location in an established mining community, roads on the property, rail just off the property and hydroelectric power lines crossing the property, making logistics simple and the cost to operate quite low.

This is the first time this property has been assembled as it is today and actively explored. A significant portion of the property has never been explored.

Market Overview

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion. The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth.

This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council. In August 2024, the market price of gold was approximately $2,435 per ounce.

Management Team

Nicole Brewster is President and CEO of Renforth Resources. During her tenure she has reconstituted the company, developed a maiden mineral resource and sold a gold deposit. She is a native of the Toronto area and has been around the mining business nearly all her life, having been raised by a successful mineral exploration geologist who worked (and is still working) around the world as an entrepreneur and geoscientist.

Ms. Brewster worked summer jobs in various segments of the mining business, which led to her employment as a contractor working in the early days of the digitization of exploration data, 3D modeling and data visualization. After working in the capital markets for a time, she returned to the mineral exploration business as a partner in a successful private firm with several employees.

Renforth Resources Inc. (OTCQB: RFHRF), closed Friday's trading session at $0.0104, off by 6.3063%, on 79,054 volume. The average volume for the last 3 months is 17,604 and the stock's 52-week low/high is $0.0068/$0.0241.

Recent News

Global Compliance Applications Corp. (CSE: APP) (OTCQB: FUAPF)

The QualityStocks Daily Newsletter would like to spotlight Global Compliance Applications Corp. (CSE: APP)(OTCQB: FUAPF).

Global Compliance Applications (CSE: APP) (OTC: FUAPF) (FSE: 2FA) ("GCAC"), a leading medical cannabis chain-of-custody compliance and data platform, has announced an expansion to its partnership with EMTRI, scaling blockchain and NFT couponing in California's cannabis market. Under the collaboration, distributors benefit from EMT token rewards, supported by a buyback program designed to stabilize token value and encourage long-term engagement. Consumers gain access to Uplift NFT couponing through the Efixii app, providing a premium and transparent experience that enhances the value of the products they purchase.

"With the launch of the EMTRI NETWORK, our smartphone app technology provides an intuitive and truthful feedback loop from the point at which our cultivators conceptualize and plant their cannabis strains and follows the crop through distribution, retail and consumption," said EMTRI CEO Eric Kennedy. "Our app can also be anonymously used by consumers to provide Efixii blockchain-protected feedback on the consumed cannabis directly to the cultivator using a simple QR-code scan."

To view the full press release, visit https://ibn.fm/0fkuj

Global Compliance Applications Corp. (CSE: APP) (OTCQB: FUAPF) is committed to improving the lives of medical cannabis patients, particularly veterans, through a blockchain-powered technology model. The Efixii Uplift platform provides an end-to-end data chain ensuring transparency and efficacy in cannabis products from cultivation to consumption. This Layer -2 Ethereum blockchain platform strengthens the relationship between cannabis brands, retailers, and consumers, driving trust and better health outcomes for veterans.

As the wars in Afghanistan and Iraq become part of history, over 16 million veterans remain central to GCAC’s mission. GCAC partners with leading veteran nonprofits in the U.S. and Canada, building trust within both the veteran community and the cannabis industry. Veterans are directed to Citizen Green TV (CGTV), GCAC’s health and wellness streaming service, which connects them with cannabis/CBD product providers, further amplifying GCAC’s impact.

Market Opportunity

The global medical cannabis market, valued at $13.8 billion in 2022, is projected to grow to $66.8 billion by 2030. With over 18.6 million U.S. and Canadian veterans, nearly 20% of whom already use cannabis and spend an average of $300 monthly, GCAC’s work with veterans serves as a powerful proof of concept. This success showcases the potential for GCAC’s blockchain platform to expand into other sectors, such as agriculture and organic farming, further demonstrating its scalability and broad market applicability.

Key Products & Initiatives

  • Efixii Uplift is GCAC’s decentralized app that connects cannabis brands, retailers, and consumers. The platform uses NFT coupons stored on a consumer’s smartphone and powered by an Ethereum wallet, ensuring both privacy and security. By leveraging blockchain technology, Efixii Uplift promotes transparency across the supply chain, enhances brand loyalty, and strengthens consumer trust.
  • Citizen Green TV (CGTV) is the first streaming service dedicated to veterans’ health, offering content focused on alternative therapies like cannabis. Cannabis companies legally advertise using Uplift NFT Coupons, reaching this targeted audience. CGTV is available on Roku, Google TV, and Apple TV, with a potential reach of 168 million viewers in North America.
  • Citizen Green Ventures, GCAC’s joint venture with Sana’a Cannabis, provides legal medical cannabis to Canadian veterans under the Veterans Affairs Canada program. VAC covers $8.50 per gram for up to three grams per day. In 2022-23 VAC reimbursed 21,108 people a total of $167.6 million.

Global Compliance Applications Corp. (OTCQB: FUAPF), closed Friday's trading session at $0.0045, up 12.5%, on 7,461 volume. The average volume for the last 3 months is 21,445 and the stock's 52-week low/high is $0.0024/$0.02.

Recent News

SuperCom Ltd. (NASDAQ: SPCB)

The QualityStocks Daily Newsletter would like to spotlight SuperCom Ltd. (NASDAQ: SPCB) .

SuperCom Ltd. (NASDAQ: SPCB) provides secured solutions for the e-government, IoT and cybersecurity sectors. Since 1988, the company has been a trusted global provider of traditional and digital identity offerings, providing cutting-edge electronic and digital security solutions to governments and organizations, both private and public, around the world.

SuperCom’s mission is to revolutionize the public safety sector worldwide through proprietary electronic monitoring technology, data intelligence, and complementary services.

The company is headquartered in Tel Aviv, Israel, with offices in California and other regions in the U.S.

Business Units

IoT and Connectivity

SuperCom IoT products and solutions provide advanced electronic monitoring solutions and services to criminal justice agencies, enabling customers to detect unauthorized movement of people, vehicles, and other monitored objects. The company provides an all-in-one, field-proven PureSecurity offender monitoring suite, accompanied by services such as GPS monitoring, home detention, domestic violence prevention, and more. The company’s services are specifically tailored to meet each client’s needs.

SuperCom’s proprietary Puresecurity suite of hardware, connectivity, and software components is the foundation for its criminal justice services and offerings. SuperCom is leveraging its extensive technology expertise to implement groundbreaking artificial intelligence (AI) technologies into various parts of its core offerings. By leveraging the power of AI, SuperCom’s PureSecurity platform can offer new abilities, such as amplified data analysis, predictive modeling, and streamlined automation – all geared toward optimizing decision-making and operational efficiency.

Competitive advantages of SuperCom’s technology include:

  • Long Battery Life (No Tag Charging Required)
  • Ultra Lightweight Form Factor
  • Next-Gen Location Tech
  • Protection of Domestic Violence Victims
  • And More

 

Cybersecurity

In 2015, SuperCom identified the cybersecurity market as a fast-growing space with significant advantages due to synergistic technologies and a shared customer base with its e-Gov and IoT business units. Consequently, SuperCom strategically acquired Prevision Ltd., a company with a strong presence in the market and a broad range of competitive cybersecurity services.

During the first quarter of 2016, SuperCom acquired Safend Ltd., an international provider of cutting-edge endpoint data protection guarding against corporate data loss and theft through content discovery and inspection, encryption methodologies, and comprehensive device and port control.

Both acquisitions significantly expanded the breadth of the company’s global cybersecurity capabilities.

e-Gov

Through proprietary e-government platforms and innovative solutions for traditional and biometrics enrollment, personalization, issuance, and border control services, SuperCom has helped governments, and national agencies design and issue secured multi-identification, or Multi-ID, documents and robust digital identity solutions to their citizens, visitors, and lands.

The company has focused on expanding its activities in the traditional identification, or ID, and electronic identification, or e-Gov, markets, including the design, development, and marketing of identification technologies and solutions to governments in Europe, Asia, America, and Africa using SuperCom’s e-Government platforms.

Market Opportunity

Data from Berg Insight estimates the market for electronic monitoring solutions will grow from $1.2 billion in 2021 to $2.1 billion in 2026, marking a CAGR of 10.8% for the forecast period.

High recidivism rates, prison overcrowding, and soaring incarceration costs are some factors that are driving the electronic monitoring of offenders’ market growth.

An analysis by ReportLinker forecasts that the global cybersecurity market will grow from an estimated value of $173.5 billion in 2022 to $266.2 billion by 2027, achieving a CAGR of 8.9% for the period.

The increased number of data breaches worldwide, the ability of malicious actors to operate from anywhere in the world, the links between cyberspace and physical systems, and the difficulty of reducing vulnerabilities and consequences in complex cyber networks are some factors driving the cybersecurity market growth.

Management Team

Ordan Trabelsi is President and CEO of SuperCom. He has over 15 years of experience as CEO, growing high-tech companies globally. He also has experience in research and development and product innovation, as well as hands-on experience in cybersecurity, encryption, advanced mathematics, and mobile and internet network technologies. Prior to joining SuperCom, he served as co-founder and CEO of Klikot Inc., a global social networking company. He holds an MBA from Columbia University and a B.Sc. in Computer Engineering from The Technion: Israel Institute of Technology.

Barak Trabelsi is COO of SuperCom. He has expertise in big data, cyber, mobile, and internet network technologies, as well as extensive experience in product development and strategies. Prior to joining SuperCom, he served as Senior Product Manager at Equinox Ltd. Before that, he served for four years as VP of R&D at Sigma Wave, a wireless, security, and internet-focused company. He holds a B.Sc. in Computer Science and Business, as well as an MBA from Tel Aviv University.

Gil Alfi is VP of Sales at Safend Ltd., SuperCom’s cybersecurity subsidiary. He joined SuperCom in 2016 as VP of Business Development for Safend. He has more than 18 years of experience in technology companies. He served as an R&D team technology lead for more than seven years and as Director of Product Management for various telecom and wireless companies for more than 10 years. Prior to joining SuperCom, he served as Regional Sales Director at Safend, managing sales regions in Europe and Africa. He holds a B.Sc. in Computer Science and Mathematics and an M.Sc. in Computer Science from Bar-Ilan University.

SuperCom Ltd. (NASDAQ: SPCB), closed Friday's trading session at $3.52, up 8.642%, on 39,224 volume. The average volume for the last 3 months is 192,495 and the stock's 52-week low/high is $2.55/$12.596.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.